Abstract
This paper shows that the exogenous delta-sleep-inducing peptide (DSIP) injected subcutaneously into rats at an age of 2–24 months of postnatal development in a dose of 100 mg/kg of animal body weight in courses for five consecutive days each month has a hepatoprotective effect. DSIP does not affect the functional activity of the pancreas and is not involved in the regulation of calcium homeostasis in the physiological aging of an organism.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
